CHNXF.US ChitogenX Inc.

Healthcare Biotechnology USA Stocks
0.0075 USD
Close of Nov 13, 2026
0.0011 0.0076
Market cap
USD 628K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Oct 2024.

Is CHNXF.US undervalued?

Graham number

The Graham number of ChitogenX Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

ChitogenX Inc. fundamental analysis

No fundamental analysis for ChitogenX Inc. yet.

ChitogenX Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About ChitogenX Inc.

ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of orthopaedic and sports medicine surgeries in Canada. It develops Ortho-R, a biopolymer for rotator cuff repair; and Ortho-M, a biopolymer for meniscus repair. The company was formerly known as Ortho Regenerative Technologies Inc. and changed its name to ChitogenX Inc. in September 202…

Full company profile